.png)
.png?width=171&height=239&name=2025%20Trends%20Report%20Nav%20(1).png)
TRILLIANT HEALTH RESEARCH
Research
Timely trend analysis. Free in your inbox.
Receive weekly studies from Trilliant Health.
One in Four Cancer Patients Had an Emergency Department Visit with a Nonspecific Finding Prior to Diagnosis, and Nearly 1/3 Waited More Than 180 Days for Confirmation
Read the StudyJanuary 14, 2024
Part 2: Harnessing Price Transparency Data to Analyze True Cost of Care
Combining data about negotiated rates, utilization and provider info enables market-level strategic insights and optimization of healthcare costs.
Katie Patton • Sanjula Jain, Ph.D. • Matt Ikard • Jim Browne
StudiesJanuary 07, 2024
Part 1: The Economic Framework of Price Transparency Data
Understanding the identity of services rendered by every provider is foundational to connecting a negotiated rate to a specific provider and location.
Katie Patton • Matt Ikard • Jim Browne • Sanjula Jain, Ph.D.
StudiesDecember 17, 2023
The Market Rate Has Been Revealed, and It Is Lower Than You Think
Our research reveals that rates vary widely within and among markets for the same healthcare services, even high-volume preventive procedures.
Katie Patton • Sanjula Jain, Ph.D. • Matt Ikard
StudiesJuly 23, 2023
Employers Have a Critical Role in Containing U.S. Healthcare Spending
Health plan price transparency should compel health economy stakeholders to compete based on cost, quality and access, which are elements of value.
Katie Patton • Sanjula Jain, Ph.D.
StudiesJune 18, 2023
National Distribution Reveals Variation in Quality, Financial and Competitive Performance Among Renowned U.S. Hospitals
Accounting for factors such as services rendered, bed size and market characteristics is critical for identifying true hospital peers.
Katie Patton • Sanjula Jain, Ph.D.
StudiesMay 21, 2023
While Originally Intended for Consumers, Health Plan Price Transparency Will Ultimately Promote Value-Based Competition
Challenges in leveraging health plan price transparency data, including errors in cardiology rates, limit accessibility and analysis for data experts.
Katie Patton • Sanjula Jain, Ph.D. • Matt Ikard • Colin Macon
StudiesMay 14, 2023
Patients Prescribed Drugs Like Ozempic® and Mounjaro® Have Increased Over 300%
The combination of demand and America’s obesity crisis has established telehealth companies to target the obesity and weight management market.
Katie Patton • Austin Miller • Sanjula Jain, Ph.D.
StudiesMay 07, 2023
Eating Disorders Among Child and Adolescent Patients Incrementally Spiked Following the Pandemic’s Onset
The pandemic exacerbated social isolation and introduced disruptions to daily routines and structure, particularly for children and adolescents.
Katie Patton • Sanjula Jain, Ph.D. • Austin Miller
StudiesApril 30, 2023
Life Science Investments Signal a Continued Focus on Oncology and Immunology
Oncology, immunology and rare disease continue to be therapeutic areas where companies have identified significant market opportunity.
Katie Patton • Sanjula Jain, Ph.D.
Interested in citing our research? Please follow this guide.
